TCR2 Therapeutics Inc. TCRR
Set alert
1.48 +1.48 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 58.11M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.60
- Beta
- 1.93
- Short ratio
- 1.29
- Inst. own
- 54.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 11, 2023
- 50-d avg
- 1.69
- 200-d avg
- 1.56
- 1y target
- 6.43
Financial health
Altman Z-Score
-7.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.3×
FY 2016 5y median -6.3× FY 2022
P/S 0.0×
FY 2016 5y median 0.0× FY 2022
P/B 0.3×
FY 2016 5y median 0.6× FY 2022
P/FCF -0.3×
FY 2016 5y median -6.7× FY 2022
EV/EBITDA -0.7×
FY 2016 5y median -4.7× FY 2022
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -303.0%
FY 2016 5y median -15.0% FY 2022
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2022
ROE -107.8%
FY 2016 5y median -29.7% FY 2022
ROIC -78.9%
FY 2016 5y median -31.9% FY 2022
ROA -72.9%
FY 2016 5y median -28.2% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2022
Operating Income -53.9%
FY 2016 FY 2022
EPS (diluted) -49.4%
FY 2016 FY 2022
Free Cash Flow -25.6%
FY 2016 FY 2022
Financial Health
Current Ratio 2.8×
FY 2016 5y median 21.7× FY 2022
Quick Ratio 2.8×
FY 2016 5y median 21.7× FY 2022
Debt / Equity 0.4×
FY 2016 5y median 0.0× FY 2022
Net Debt / EBITDA -0.2×
FY 2016 5y median 1.4× FY 2022
Interest Coverage -2.6×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31